| HSP90 inhibitors: current development and potential in cancer therapy K Sidera, E Patsavoudi Recent patents on anti-cancer drug discovery 9 (1), 1-20, 2014 | 315 | 2014 |
| A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2 K Sidera, M Gaitanou, D Stellas, R Matsas, E Patsavoudi Journal of Biological Chemistry 283 (4), 2031-2041, 2008 | 202 | 2008 |
| Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell … D Stellas, A El Hamidieh, E Patsavoudi BMC cell biology 11, 1-9, 2010 | 178 | 2010 |
| Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system K Sidera, M Samiotaki, E Yfanti, G Panayotou, E Patsavoudi Journal of Biological Chemistry 279 (44), 45379-45388, 2004 | 159 | 2004 |
| Extracellular HSP90: conquering the cell surface K Sidera, E Patsavoudi Cell cycle 7 (11), 1564-1568, 2008 | 114 | 2008 |
| Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. L Probert, J Keffer, P Corbella, H Cazlaris, E Patsavoudi, S Stephens, ... Journal of immunology (Baltimore, Md.: 1950) 151 (4), 1894-1906, 1993 | 112 | 1993 |
| Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis D Stellas, A Karameris, E Patsavoudi Clinical Cancer Research 13 (6), 1831-1838, 2007 | 93 | 2007 |
| Extracellular molecules involved in cancer cell invasion T Stivarou, E Patsavoudi Cancers 7 (1), 238-265, 2015 | 76 | 2015 |
| Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion A El Hamidieh, N Grammatikakis, E Patsavoudi Public Library of Science 7 (8), e42722, 2012 | 45 | 2012 |
| BM88 is an early marker of proliferating precursor cells that will differentiate into the neuronal lineage Y Koutmani, C Hurel, E Patsavoudi, M Hack, M Gotz, D Thomaidou, ... European Journal of Neuroscience 20 (10), 2509-2523, 2004 | 41 | 2004 |
| Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo T Stivarou, D Stellas, G Vartzi, D Thomaidou, E Patsavoudi Cancer biology & therapy 17 (8), 799-812, 2016 | 35 | 2016 |
| Characterization and localization of the BM88 antigen in the developing and adult rat brain E Patsavoudi, E Merkouri, D Thomaidou, F Sandillon, G Alonso, R Matsas Journal of neuroscience research 40 (4), 506-518, 1995 | 31 | 1995 |
| The BM88 Antigen, a Novel Neuron-specific Molecule, Enhances the Differentiation of Mouse Neuroblastoma Cells∗ A Mamalaki, E Boutou, C Hurel, E Patsavoudi, S Tzartos, R Matsas Journal of Biological Chemistry 270 (23), 14201-14208, 1995 | 30 | 1995 |
| Neuron-and myelin-specific monoclonal antibodies recognizing cell-surface antigens of the central and peripheral nervous system E Patsavoudi, C Hurel, R Matsas Neuroscience 30 (2), 463-478, 1989 | 27 | 1989 |
| Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment D Stellas, E Patsavoudi Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2012 | 26 | 2012 |
| Identification of a novel neuron-specific surface antigen in the developing nervous system, by monoclonal antibody 4C5 D Thomaidou, E Patsavoudi Neuroscience 53 (3), 813-827, 1993 | 25 | 1993 |
| The 4C5 cell-impermeable anti-HSP90 antibody with anti-cancer activity, is composed of a single light chain dimer K Sidera, A El Hamidieh, A Mamalaki, E Patsavoudi PloS one 6 (9), e23906, 2011 | 23 | 2011 |
| Purification and characterization of neuron‐specific surface antigen defined by monoclonal antibody BM88 E Patsavoudi, C Hurel, R Matsas Journal of neurochemistry 56 (3), 782-788, 1991 | 23 | 1991 |
| Developmental expression and functional characterization of the 4C5 antigen in the postnatal cerebellar cortex D Thomaidou, I Dori, E Patsavoudi Journal of neurochemistry 64 (5), 1937-1944, 1995 | 16 | 1995 |
| Extracellular HSP90: an emerging target for cancer therapy K Sidera, E Patsavoudi Current Signal Transduction Therapy 4 (1), 51-58, 2009 | 15 | 2009 |
